Q2 2014 Holdings
Filed 2014-08-14 | 107 holdings | $785.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $462.7M | 20,481,442 | 58.9% |
| Biocryst Pharmaceuticals Inc.(BCRX) | COM | 09058V103 | $138.9M | 10,890,872 | 17.7% |
| Biomarin Pharmaceuticals(BMRN) | COM | 09061G101 | $118.7M | 1,908,230 | 15.1% |
| Cerus(CERS) | COM | 157085101 | $42.5M | 10,246,591 | 5.4% |
| Agios Pharmaceuticals(AGIO) | COM | 00847X104 | $9.2M | 199,893 | 1.2% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $5.6M | 2,223,053 | 0.7% |
| Synageva Biopharma Corp. | COM | 87159A103 | $1.1M | 10,660,432 | 0.1% |
| Pharmacyclics Inc. | COM | 716933106 | $860.5K | 9,591,546 | 0.1% |
| Seattle Genetics, Inc. | COM | 812578102 | $859.6K | 22,472,229 | 0.1% |
| Incyte Corp.(INCY) | COM | 45337C102 | $837.9K | 14,845,559 | 0.1% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | COM | 02043Q107 | $733.0K | 11,600 | 0.1% |
| Salix 2.75% 5/15/15 | CONV BONDS | 795435AC0 | $585.8K | $219,440,000 | 0.1% |
| Genomic Health Inc.(GHDX) | COM | 37244C101 | $374.1K | 13,654,902 | 0.0% |
| Incyte Corporation Notes 1.25% 11/15/2020 144A | CONV BONDS | 45337CAL6 | $371.6K | $274,500,000 | 0.0% |
| Incyte Corporation Notes 0.375% 11/15/2018 144A | CONV BONDS | 45337CAK8 | $346.0K | $259,000,000 | 0.0% |
| Incyte Corporation Notes 4.75% 10/1/2015 144A | CONV BONDS | 45337CAJ1 | $259.3K | $40,446,000 | 0.0% |
| Intermune Inc. | COM | 45884X103 | $208.5K | 4,722,869 | 0.0% |
| Intermune Inc Notes 2.5% 12/15/17 | CONV BONDS | 45884XAF0 | $141.2K | $41,000,000 | 0.0% |
| Xoma Corp. | COM | 98419J107 | $105.9K | 23,065,972 | 0.0% |
| Avanir Pharmaceuticals | COM CLASS A | 05348P401 | $104.7K | 18,558,487 | 0.0% |
| Gilead 1.625% 5/1/16 | CONV BONDS | 375558AP8 | $78.4K | $21,500,000 | 0.0% |
| Vanda Pharmaceuticals, Inc.(VNDA) | COM | 921659108 | $70.7K | 4,372,153 | 0.0% |
| Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 | CONV BONDS | 09061GAD3 | $70.5K | $22,898,000 | 0.0% |
| Anacor Pharmaceuticals | COM | 032420101 | $57.6K | 3,248,043 | 0.0% |
| Medivation 2.625% 4/1/17 | CONV BONDS | 58501NAA9 | $55.3K | $34,720,000 | 0.0% |
| Dyax Corp. | COM | 26746E103 | $54.5K | 5,681,237 | 0.0% |
| Repros Therapeutics | COM | 76028H209 | $48.1K | 2,778,654 | 0.0% |
| Mirati Therapeutics Inc.(MRTXEUR) | COM | 60468T105 | $47.6K | 2,380,074 | 0.0% |
| Questcor Pharmaceuticals, Inc. | COM | 74835Y101 | $46.2K | 500,000 | 0.0% |
| Derma Sciences | COM | 249827502 | $40.9K | 3,537,137 | 0.0% |
| Intermune Inc Notes 5% 3/1/15 | CONV BONDS | 45884XAD5 | $39.8K | $16,860,000 | 0.0% |
| Versartis Inc. | COM | 92529L102 | $34.9K | 1,245,889 | 0.0% |
| Clovis Oncology(CLVSEUR) | COM | 189464100 | $32.8K | 793,221 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $32.1K | 2,607,784 | 0.0% |
| Acorda Therapeutics, Inc. | COM | 00484M106 | $30.5K | 906,091 | 0.0% |
| Salix 1.5% 3/15/19 | CONV BONDS | 795435AE6 | $29.4K | $15,000,000 | 0.0% |
| Halozyme Therapeutics Inc.(HALO) | COM | 40637H109 | $27.4K | 2,776,143 | 0.0% |
| Gilead Sciences Inc.(GILD) | COM | 375558103 | $21.2K | 256,108 | 0.0% |
| Arrowhead Research Corp. | COM | 042797209 | $20.5K | 1,430,802 | 0.0% |
| TG Therapeutics(TGTX) | COM | 88322Q108 | $20.3K | 2,160,965 | 0.0% |
| Xenoport | COM | 98411C100 | $19.5K | 4,034,112 | 0.0% |
| Progenics Pharmaceuticals, Inc. | COM | 743187106 | $19.2K | 4,449,797 | 0.0% |
| Salix Pharmaceuticals Ltd Put 110 July 14 | COM | 795435956 | $15.4K | 125,100 | 0.0% |
| Aegerion Pharmaceuticals | COM | 00767E102 | $13.3K | 413,922 | 0.0% |
| Omeros Corp.(OMER) | COM | 682143102 | $13.1K | 753,804 | 0.0% |
| Biomarin Pharmaceuticals Notes 0.75% 10/15/2018 | CONV BONDS | 09061GAE1 | $12.9K | $12,500,000 | 0.0% |
| Kythera Biopharmaceuticals | COM | 501570105 | $11.9K | 311,255 | 0.0% |
| Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | $11.4K | 1,211,851 | 0.0% |
| QLT Inc. | COM | 746927102 | $9.5K | 1,535,863 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $8.2K | 554,590 | 0.0% |